{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in parkin account for approximately 50% of all ARJP cases. Parkin is a multidomain E3 ligase that contains an N-terminal ubiquitin-like domain (Ubld) that interacts with, and effects the ubiquitination of, substrates such as cyclin E, p38 and synphilin.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the R42P variant, linking it to autosomal recessive juvenile Parkinson's disease through impaired E3 ligase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used urea unfolding experiments and NMR spectroscopy to examine the structure and stability of wild-type Ubld and the protein carrying the R42P mutation.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (urea unfolding and NMR spectroscopy) effectively models the disease pathogenesis by assessing the structural integrity and stability of the parkin Ubld, which is crucial for its function in the ubiquitination pathway.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The R42P mutation was shown to cause the complete unfolding of the parkin Ubld, as determined by NMR spectroscopy of a GB1-Ubld R42P fusion protein.",
          "judgment": "Yes",
          "reasoning": "The assay included basic controls (wild-type Ubld and ubiquitin) and the specific instance of the assay (NMR spectroscopy) provided clear evidence of the structural impact of the R42P mutation.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The R42P mutation causes the global unfolding of the Ubld, leading to dysfunction of the protein in the ubiquitination pathway.",
          "judgment": "Yes",
          "reasoning": "The evidence strongly supports the pathogenic nature of the R42P mutation due to its drastic alteration of the Ubld structure, leading to loss of function.",
          "next_step_or_outcome": "Final evidence strength assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The R42P mutation in PARK2 leads to complete unfolding of the Ubld domain, significantly impairing parkin's function in the ubiquitination pathway, supporting a very strong pathogenic evidence strength (PS3_very_strong)."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": "48"
        },
        "variant_string_id": "PARK2 K48A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in parkin account for approximately 50% of all ARJP cases. Parkin is a multidomain E3 ligase that contains an N-terminal ubiquitin-like domain (Ubld) that interacts with, and effects the ubiquitination of, substrates such as cyclin E, p38 and synphilin.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the K48A variant, linking it to autosomal recessive juvenile Parkinson's disease through potential impairment of E3 ligase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used urea unfolding experiments to examine the stability of wild-type Ubld and the protein carrying the K48A mutation.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (urea unfolding) effectively models the disease pathogenesis by assessing the stability of the parkin Ubld, which is crucial for its function in the ubiquitination pathway.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The K48A mutation was found to have little effect on the stability of the parkin Ubld or ubiquitin, indicating that this mutation contributes to defective protein-protein interactions.",
          "judgment": "Yes",
          "reasoning": "The assay included basic controls (wild-type Ubld and ubiquitin) and the specific instance of the assay provided clear evidence of the minimal impact of the K48A mutation on protein stability.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The K48A mutation retains the Ubld but likely leads to a modified interaction with the S5a subunit of the proteasome.",
          "judgment": "Yes",
          "reasoning": "The evidence suggests that the K48A mutation may impair parkin's function through defective protein-protein interactions rather than structural destabilization.",
          "next_step_or_outcome": "Final evidence strength assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The K48A mutation in PARK2 minimally affects the stability of the Ubld domain but may impair function through defective protein-protein interactions, supporting a supporting pathogenic evidence strength (PS3_supporting)."
    }
  ]
}